Navigation Links
CareFusion Corp to be Included in S&P 500 Index
Date:8/25/2009

SAN DIEGO, Aug. 25 /PRNewswire-FirstCall/ -- CareFusion Corporation announced today that its stock will be included in the S&P 500 index following the company's planned spinoff from Cardinal Health on Aug. 31. CareFusion stock will be added to the index on Sept. 1, coinciding with its first day of regular-way trading on the New York Stock Exchange under the symbol "CFN."

"Our inclusion in the S&P 500 is a testament to our position in the industry as we launch a new public company dedicated to helping hospitals improve patient care and safety, both domestically and around the world," said David Schlotterbeck, chief executive officer of CareFusion. "We are pleased to be recognized among such a select group of U.S. companies."

CareFusion provides products and services designed to help measurably improve patient care in two major areas: medication errors and hospital-acquired infections. The company's common stock began trading on a "when issued" basis on Aug. 21. On Aug. 31, "when issued" trading is scheduled to end and "regular way" trading is scheduled to begin on Sept. 1 under the ticker symbol "CFN."

Regarded as one of the best single gauges of the U.S. equities market, the S&P 500 index includes 500 leading companies in leading industries of the U.S. economy.

About CareFusion Corporation

CareFusion Corporation is currently a wholly owned subsidiary of Cardinal Health (NYSE: CAH). The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of care. CareFusion develops market-leading technologies including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, AVEA(R) and Pulmonetic Systems(TM) ventilation and respiratory products, ChloraPrep(R) for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller(R) surgical instruments and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations. The company has been authorized to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN." More information may be found at carefusion.com.

Cautions concerning forward-looking statements

This news release contains forward-looking statements addressing the planned spinoff of the clinical and medical products businesses of Cardinal Health as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10, as amended, and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those filings and reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CareFusion Issues Update Regarding Previously Disclosed June 12, 2009 Recall of the Alaris(R) System
2. CareFusion Form 10 Registration Statement Declared Effective
3. CareFusion Expands Pyxis(R) Perioperative Solutions Offering
4. CareFusion Prices $1.4 Billion of Senior Notes
5. Cardinal Health Board of Directors Approves CareFusion Spinoff
6. CareFusion to Resume Shipping Alaris(R) Infusion Products
7. CareFusion Corporation Launches International Jazz Festival Series
8. CareFusion Files Amended Form 10 Registration Statement With SEC
9. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
10. CareFusion Names Robert Friel to Board of Directors
11. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , ... May 27, 2016 , ... W.S. Badger ... announced today that it has been recognized as one of the best small businesses ... was named as one of nine small businesses providing progressive benefits to new parents ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... with Mediaplanet to help educate the many who are unaware of the plight ... to aphasia will run within the “Stroke Awareness” campaign. , The link between ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation ... providing proof of successfully certified products, services and staff. , Validation Center is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia ... negative impact on long-term patient survival, reports a team of UPMC researchers in ... week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... England , May 25, 2016 ... company employing the precision of circulating tumour DNA ... today announces the appointment of Professor Clive ... provide medical leadership across the clinical development programme, ... Inivata,s products help deliver significant improvements in clinical ...
Breaking Medicine Technology: